These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 32198194)

  • 1. Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease.
    Chait A; Ginsberg HN; Vaisar T; Heinecke JW; Goldberg IJ; Bornfeldt KE
    Diabetes; 2020 Apr; 69(4):508-516. PubMed ID: 32198194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
    Taskinen MR; Matikainen N; Björnson E; Söderlund S; Inkeri J; Hakkarainen A; Parviainen H; Sihlbom C; Thorsell A; Andersson L; Adiels M; Packard CJ; Borén J
    Diabetologia; 2023 Dec; 66(12):2307-2319. PubMed ID: 37775612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
    Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
    J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis.
    Nakajima K; Tanaka A
    Clin Chim Acta; 2018 Mar; 478():200-215. PubMed ID: 29307667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
    Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis.
    Nakajima K; Tanaka A
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):108-117. PubMed ID: 29493553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.
    Mjos OD; Faergeman O; Hamilton RL; Havel RJ
    J Clin Invest; 1975 Sep; 56(3):603-15. PubMed ID: 169294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothesis II: The majority of VLDL-apoB48 remnants in postprandial plasma are derived from the liver, not from the intestine.
    Nakajima K; Tokita Y; Tanaka A
    Clin Chim Acta; 2019 Mar; 490():12-16. PubMed ID: 30553860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of high density lipoproteins in regulation of hepatic fatty acid synthesis by chylomicron and very low density lipoprotein remnants.
    Lakshmanan MR; Maten MV; Muesing RA; O'Looney P; Vahouny GV
    J Biol Chem; 1983 Apr; 258(8):4746-9. PubMed ID: 6833273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins.
    Gotto AM
    Am J Cardiol; 1990 Sep; 66(6):20A-23A. PubMed ID: 2203246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remnant lipoproteins: are they equal to or more atherogenic than LDL?
    Salinas CAA; Chapman MJ
    Curr Opin Lipidol; 2020 Jun; 31(3):132-139. PubMed ID: 32332433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat.
    Windler E; Chao Y; Havel RJ
    J Biol Chem; 1980 Jun; 255(11):5475-80. PubMed ID: 7372646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations.
    Taskinen MR; Björnson E; Matikainen N; Söderlund S; Rämö J; Ainola MM; Hakkarainen A; Sihlbom C; Thorsell A; Andersson L; Bergh PO; Henricsson M; Romeo S; Adiels M; Ripatti S; Laakso M; Packard CJ; Borén J
    JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36040803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk.
    Baratta F; Cocomello N; Coronati M; Ferro D; Pastori D; Angelico F; Ben MD
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease.
    Duran EK; Pradhan AD
    Clin Chem; 2021 Jan; 67(1):183-196. PubMed ID: 33409533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of removal of lipoproteins of different composition on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and hepatic very low density lipoprotein secretion.
    Van Zuiden PE; Erickson SK; Cooper AD
    J Lipid Res; 1983 Apr; 24(4):418-28. PubMed ID: 6854151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.